SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Telma Sequeira

Telma Sequeira

Instituto Português de Oncologia de Lisboa (IPO Lisboa), Lisbon

Dr Telma Sequeira is a consultant pulmonologist at the Instituto Português de Oncologia de Lisboa Francisco Gentil (IPO Lisboa) in Lisbon, Portugal. Her clinical and research work focuses on thoracic oncology and non-small cell lung cancer, alongside interventional pulmonology and sleep medicine. She also practises at Hospital CUF Tejo and is an invited assistant in medical genetics at the Faculty of Medicine, University of Lisbon.

She sits on the scientific committee of the Portuguese Lung Cancer Study Group (GECP) and was the first Portuguese pulmonologist to join the IASLC lung cancer staging project. Her research spans NSCLC and immunotherapy, and she is pursuing doctoral studies at the Centro Académico de Medicina de Lisboa. She is a member of ESMO, ASCO, IASLC and the European Respiratory Society.

Connect

Telma Sequeira

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates